CHEST Journal: Peer-Reviewed. Cutting-Edge.

Highlights from April

This month’s handpicked reading list

CHEST INFECTIONS

Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor

A prospective longitudinal study shows that elexacaftor/tezacaftor/ivacaftor is associated with substantial benefits in health outcomes.

VISIT THE EQUITY TOPIC COLLECTION »


COPD

Individual Risk Factors of PM2.5 Associated With Wintertime Mortality in Urban Patients With COPD

A study of 19,243 deceased veterans with prior COPD diagnosis finds wintertime PM2.5 exposure was associated with elevated mortality risk in people with COPD.

VISIT THE EQUITY TOPIC COLLECTION »


CRITICAL CARE

Use and Outcomes of Peripheral Vasopressors in Early Sepsis-Induced Hypotension Across Michigan Hospitals

A retrospective cohort study shows peripheral vasopressor initiation had practical benefits, including expedited vasopressor administration and avoidance of central line placement in one-third of patients.

RELATED VISUAL ABSTRACT »


DIFFUSE LUNG DISEASE

Urban-Rural Differences in Idiopathic Pulmonary Fibrosis-Related Mortality Rates in the United States

This population-based study examines the urban and rural differences in idiopathic pulmonary fibrosis clinical syndrome-related mortality rates in the United States.

VISIT THE EQUITY TOPIC COLLECTION »


PULMONARY VASCULAR

Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy

A real-world cohort study shows that patients with pulmonary arterial hypertension with left heart disease risk factors were less likely to be exposed to initial combination therapy.

RELATED VISUAL ABSTRACT »


THORACIC ONCOLOGY

A Nasal Swab Classifier to Evaluate the Probability of Lung Cancer in Patients With Pulmonary Nodules

Original research shows that the nasal classifier provides an accurate assessment of probability of lung cancer in individuals with pulmonary nodules ≤30 mm who smoke or have previously smoked.


CHEST Journal image

Each month, the journal CHEST® features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine. It also houses our highly regarded clinical practice guidelines and consensus statements.

In addition, readers can find the latest research posted in the Online First section each week and access series that provide insight into relevant clinical areas and address controversial issues, fostering discussion among physicians.

READ THE CURRENT ISSUE


All CHEST members receive a free online subscription to the journal CHEST. Not yet a member? See what CHEST has to offer »


CME for CHEST Journal
CHEST now offers CME credit for journal readers! Several articles are eligible each month; look for the symbol throughout the CHEST website. To claim, log in to your CHEST account (or quickly create a free one if you're new to CHEST), find the article you’ve read, and complete the posttest.

CHEST Critical Care and CHEST Pulmonary image

Browse other journals in the CHEST portfolio

CHEST® Critical Care, a new open access journal, will advance the care of patients served by multidisciplinary clinicians across critical care medicine.

CHEST® Pulmonary, a new open access journal, will advance the care of patients served by multidisciplinary clinicians across pulmonary and sleep medicine.

Advertisement

Latest podcasts: Now streaming

Twitter icon

CHEST Journal

What did you find most interesting this month? Send us a message @journal_CHEST.

 
Facebook icon Twitter icon Linked in icon YouTube icon Instagram icon

Easy viewing. In-depth information.

Watch the latest CHEST journal webinar.

Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension

Journal CHEST® authors, Daniel Lachant, DO, and R. James White, MD, PhD, discuss the article, "Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension."

Moderator: Nicholas A. Kolaitis, MD, MAS

Peter J. Mazzone, MD, MPH, FCCP

General Information

Editor in Chief:
Peter J. Mazzone, MD, MPH, FCCP

Published monthly
Archived back to 1935


Submission/Review Stats

Acceptance rate: 8-10% for Original Research

Time to first decision: 3 weeks

Acceptance to publication: 2 to 3 weeks to Online First, 5 months to print

READY TO SUBMIT TO CHEST JOURNAL?
Learn how to submit original research for consideration.

CHEST SUBMISSIONS »

Numbers to be proud of

10.1

Impact Factor

5th

Impact Factor Rank

4.2

Immediacy Index

0.04858

Eigenfactor Score

3.681

Article Influence Score

When you become a member of CHEST, you’ll be automatically subscribed to the journal CHEST and receive alerts on the latest research as well as discounts on all that we offer.

GET THE LATEST RESEARCH UPDATES

Nonmembers and institutions can subscribe by contacting Elsevier Customer Service for assistance or -Tel: + 1 (800) 654-2452 (United States and Canada); + 1 (314) 447-8871 (outside United States and Canada).